Reason for request
Inscription
Mise à disposition d'un générique d'Evoltra.
Clinical Benefit
| Substantial |
le service médical rendu par CLOFARABINE TILLOMED 1 mg/ml est important dans l’indication de l’AMM. |
Clinical Added Value
| no clinical added value |
Cette spécialité n’apporte pas d’amélioration du service médical rendu (ASMR V) par rapport à la spécialité princeps EVOLTRA 1 mg/ml, déjà inscrite. |
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
UbCwayUwQR1scqsC
Listen
